4.8 Article

Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma

期刊

ADVANCED MATERIALS
卷 29, 期 16, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201604932

关键词

-

资金

  1. Marie Curie International Incoming Fellowship within the 7th Framework Programme [299936]
  2. Department of Bioengineering, Imperial College London
  3. Fight for Sight (UK)
  4. National Glaucoma Research Program of the BrightFocus Foundation
  5. National Eye Institute [EY022359]
  6. European Research Council Consolidator Grant [ERC-2013-CoG 617336 BTVI]
  7. Rosetrees Trust
  8. ERC Seventh Framework Programme Consolidator grant Naturale CG [616417]
  9. Engineering and Physical Sciences Research Council (EPSRC) [EP/K020641/1]
  10. Wellcome Trust [098411/Z/12/Z]
  11. EPSRC [EP/K020641/1] Funding Source: UKRI
  12. Engineering and Physical Sciences Research Council [EP/K020641/1] Funding Source: researchfish
  13. Fight for Sight [1385/86] Funding Source: researchfish
  14. Rosetrees Trust [M216] Funding Source: researchfish

向作者/读者索取更多资源

Nitric oxide (NO) is able to lower intraocular pressure (IOP); however, its therapeutic effects on outflow physiology are location-and dose-dependent. A NO delivery platform that directly targets the resistance-generating region of the conventional outflow pathway and locally liberates a controlled dose of NO is reported. An increase in outflow facility (decrease in IOP) is demonstrated in a mouse model.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据